Incyte to Present at the Canaccord Genuity 33rd Annual Growth Conference

  Incyte to Present at the Canaccord Genuity 33rd Annual Growth Conference

Canaccord Genuity Global Growth Conference 2013

Business Wire

WILMINGTON, Del. -- August 5, 2013

Incyte Corporation (Nasdaq:INCY) announced today it will present at the
Canaccord Genuity 33^rd Annual Growth Conference on Wednesday, August 14 at
10:30 a.m. (EDT) in Boston.

The presentation will be webcast live and can be accessed at www.incyte.com
under Investor Relations, Events and Webcasts. A replay of the presentation
will be available. Investors interested in listening to the live webcast
should log on before the start time in order to download any software
required.

Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company
focused on the discovery, development and commercialization of proprietary
small molecule drugs for oncology and inflammation. For additional information
on Incyte, please visit the Company's web site at www.incyte.com.

Contact:

Incyte Corporation
Pamela M. Murphy
Vice President, Investor Relations & Corporate Communications
302-498-6944
 
Press spacebar to pause and continue. Press esc to stop.